Literature DB >> 12504396

Ultrasonography in the diagnosis and management of developmental hip dysplasia (UK Hip Trial): clinical and economic results of a multicentre randomised controlled trial.

Diana Elbourne1, Carol Dezateux, Rosemary Arthur, N M P Clarke, Alastair Gray, Andy King, Anne Quinn, Frances Gardner, Glynn Russell.   

Abstract

BACKGROUND: Clinical screening aims to identify and treat neonatal hip instability associated with increased risk of hip displacement, but risks failures of diagnosis and treatment (abduction splinting), iatrogenic effects, and costs to parents and health services. Our objectives were to assess clinical effectiveness and net cost of ultrasonography compared with clinical assessment alone, to provide guidance for management of infants with clinical hip instability.
METHODS: Infants with clinical hip instability were recruited from 33 centres in UK and Ireland and randomised to either ultrasonographic hip examination (n=314) or clinical assessment alone (n=315). The primary outcome was appearance on hip radiographs by 2 years. Secondary outcomes included surgical treatment, abduction splinting, level of mobility, resource use, and costs. Analysis was by intention to treat.
FINDINGS: Protocol compliance was high, and radiographic information was available for 91% of children by 12-14 months and 85% by 2 years. By age 2 years, subluxation, dislocation, or acetabular dysplasia were identified by radiography on one or both hips of 21 children in each of the groups (relative risk 1.00; 95% CI 0.56-1.80). Fewer children in the ultrasonography group had abduction splinting in the first 2 years than did those in the no-ultrasonography group (0.78; 0.65-0.94; p=0.01). Surgical treatment was required by 21 infants in the ultrasonography group (6.7%) and 25 (7.9%) in the no-ultrasonography group (0.84; 0.48-1.47). One child from the ultrasonography group and four from the no-ultrasonography group were not walking by 2 years (0.25; 0.03-2.53; p=0.37). Infants in the ultrasonography group incurred significantly higher ultrasound costs over the first 2 years (pound 42 vs pound 23, mean difference pound 19, 95% CI 11-27); total hospital costs were lower for those infants, but the difference was not significant.
INTERPRETATION: The use of ultrasonography in infants with screen-detected clinical hip instability allows abduction splinting rates to be reduced, and is not associated with an increase in abnormal hip development, higher rates of surgical treatment by 2 years of age, or significantly higher health-service costs.

Entities:  

Mesh:

Year:  2002        PMID: 12504396     DOI: 10.1016/s0140-6736(02)12024-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  34 in total

1.  Hip dysplasia and ultrasound imaging of whole populations: the precautionary principle revisited.

Authors:  D Elbourne; C Dezateux
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

2.  Etamsylate for prevention of periventricular haemorrhage.

Authors:  R W Hunt
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

Review 3.  Ultrasonography in screening for developmental dysplasia of the hip in newborns: systematic review.

Authors:  Nerys F Woolacott; Milo A Puhan; Johann Steurer; Jos Kleijnen
Journal:  BMJ       Date:  2005-06-01

4.  The hip trial: psychosocial consequences for mothers of using ultrasound to manage infants with developmental hip dysplasia.

Authors:  F Gardner; C Dezateux; D Elbourne; A Gray; A King; A Quinn
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-01       Impact factor: 5.747

5.  Sonographic screening for developmental dysplasia of the hip in preterm breech infants: do current guidelines address the specific needs of premature infants?

Authors:  J Lee; R M Spinazzola; N Kohn; M Perrin; R L Milanaik
Journal:  J Perinatol       Date:  2016-02-25       Impact factor: 2.521

6.  What Risk Factors and Characteristics Are Associated With Late-presenting Dislocations of the Hip in Infants?

Authors:  Kishore Mulpuri; Emily K Schaeffer; Janice Andrade; Wudbhav N Sankar; Nicole Williams; Travis H Matheney; Scott J Mubarak; Peter J Cundy; Charles T Price
Journal:  Clin Orthop Relat Res       Date:  2016-05       Impact factor: 4.176

Review 7.  Developmental dysplasia of the hip: What has changed in the last 20 years?

Authors:  Pavel Kotlarsky; Reuben Haber; Victor Bialik; Mark Eidelman
Journal:  World J Orthop       Date:  2015-12-18

8.  Performance, treatment pathways, and effects of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom.

Authors:  C Dezateux; J Brown; R Arthur; J Karnon; A Parnaby
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

9.  Efficiency of alternative policy options for screening for developmental dysplasia of the hip in the United Kingdom.

Authors:  J Brown; C Dezateux; J Karnon; A Parnaby; R Arthur
Journal:  Arch Dis Child       Date:  2003-09       Impact factor: 3.791

10.  Developmental dysplasia of the hip and occult neurologic disorders.

Authors:  A Z Luther; N M P Clarke
Journal:  Clin Orthop Relat Res       Date:  2008-01-30       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.